BRIEF-Biohaven Enters Strategic Licensing Agreement With Ono Pharma

2

Oct 8 (Reuters) – ONO PHARMACEUTICAL CO., LTD.: * BIOHAVEN ENTERS STRATEGIC LICENSING AGREEMENT WITH ONO PHARMA FOR EXTRACELLULAR IGG DEGRADERS IN JAPAN AND SELECT ASIAN REGIONS, LEAD CANDIDATE BHV-

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)